Publication | Closed Access

The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study

InfertilityHormonal ContraceptiveFertilityFemale InfertilityReproductive HealthGynecologyOocyte MaturationProspective RandomizedReproductive MedicineReproductive HormoneHuman ReproductionPublic HealthEndocrinologyMedicineGnrh AntagonistOvarian HormoneWomen's HealthOvarian Cancer